VAS-UP: “UPgrading multilevel methods of assessing toxicity from steroids in VASculitis and other related conditions“ The researchers would welcome your participation in phase 1b of this Oxford University study. They are …
Schools Prize – “Science in Medicine”
Inspiring the scientists of tomorrow Vasculitis UK is so pleased to announce that we have co-sponsored the Fourth Annual “Science in Medicine School Teams Prize” to engage sixth-form school students with …
Results of symptoms survey
Vasculitis UK helped recruit a population of patients with vasculitis (with or without neuropathy) to complete an anonymous online survey for research on symptoms associated with neuropathy, led by Michael …
A very different study
The University of Nottingham is running a study, funded by Vasculitis UK, into how mental imagery and art can improve our health. They are looking for “Eight people living with …
VUK speakers at UKIVAS course
UKIVAS (UK and Ireland Vasculitis Rare Disease Group) held a Vasculitis Educational Course in Manchester on 20th/21st November 2023. The course was attended by around 70 attendees including junior doctors, …
Covid treatments and vaccines
The NHS have published guidelines for those who are entitled to have anti virals should they contract covid. They have also published a explanation of who qualifies for a booster jab …
John Mills MBE: Donate in memory
If you would like to donate to VUK in John Mills’ memory, please click on this link.John worked tirelessly for Vasculitis UK, he was very passionate about creating awareness and …
John Mills MBE, 1943-2023
We are very sad to report that John Mills, former chair of Vasculitis UK, died on Monday 28th August.We are working on a profile of his life and immense contribution …
ANCA trial
The HAVEN trial, headed by Professor David D’Cruz at Guys and St Thomas’, is looking to find out whether a drug used in Lupus can also treat Vasculitis. You may …
EULAR recommendations for ANCA-associated Vasculitis – updated
EULAR Recommendations for ANCA-associated Vasculitis – updated EULAR has published their 2022 update on recommendations for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).